Flu pandemic

Clinova Offers 50% Off Covaflu Respirator Mask for Vulnerable Members of the Community

Retrieved on: 
Wednesday, July 15, 2020
Articles, Health, Animal virology, Medicine, Global health, RTT, Prevention, Flu pandemic, Protective gear, Swine influenza, Influenza, Spanish flu

This will help ensure that vulnerable people have access to the best forms of protection against potential viral infection.

Key Points: 
  • This will help ensure that vulnerable people have access to the best forms of protection against potential viral infection.
  • The FFP2 Covaflu mask is available to members of the public from 5.83 at covaflu.com .
  • Anyone shielding or vulnerable can enter the discount code Shielding50 to receive 50% off the cost of the mask.
  • Covaflu respirator masks were first launched by Clinova in the UK in 2007, proving essential during the previous swine flu and avian flu pandemics.

Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate

Retrieved on: 
Tuesday, July 14, 2020
Vaccination, Medical specialties, RTT, Medicine, Vaccines, Virology, Influenza vaccine, Influenza vaccines, Vaccine, Flu pandemic, Influenza, Medicago

QUEBEC CITY, July 14, 2020 /CNW/ - Medicago , a biopharmaceutical company headquartered in Quebec City, began Phase I clinical trials for its plant-derived COVID-19 vaccine candidate yesterday, administering the first doses in healthy human volunteers.

Key Points: 
  • QUEBEC CITY, July 14, 2020 /CNW/ - Medicago , a biopharmaceutical company headquartered in Quebec City, began Phase I clinical trials for its plant-derived COVID-19 vaccine candidate yesterday, administering the first doses in healthy human volunteers.
  • "We are thrilled to see our COVID-19 vaccine candidate enter the Phase 1 trial, and we look forward to obtaining safety and immunogenicity results in October," said Nathalie Landry, Executive Vice-President, Scientific and Medical Affairs at Medicago.
  • Medicago is the only company with plant-based manufacturing technology that has completed Phase III clinical trials (with its quadrivalent VLP influenza vaccine candidate) and pandemic Phase II clinical trials (with its H1N1 pandemic vaccine candidate).
  • As soon as the genetic sequence of a virus is made available, Medicago can develop a clinical-grade vaccine candidate in only a few weeks.

Medicago Begins Phase I Clinical Trials for its COVID-19 Vaccine Candidate

Retrieved on: 
Tuesday, July 14, 2020
Health, Infectious diseases, Other Health, Clinical trials, Pharmaceutical, Biotechnology, Vaccination, Drugs, Vaccines, RTT, Adjuvants, Influenza vaccine, Influenza vaccines, Vaccine, Influenza, Flu pandemic, H5N1 clinical trials, Influenza research

Medicago , a biopharmaceutical company headquartered in Quebec City, began Phase I clinical trials for its plant-derived COVID-19 vaccine candidate yesterday, administering the first doses in healthy human volunteers.

Key Points: 
  • Medicago , a biopharmaceutical company headquartered in Quebec City, began Phase I clinical trials for its plant-derived COVID-19 vaccine candidate yesterday, administering the first doses in healthy human volunteers.
  • Medicago will be testing its vaccine candidate with two adjuvants separately GSK s proprietary pandemic adjuvant technology and Dynavax s CpG 1018 .
  • Medicago is the only company with plant-based manufacturing technology that has completed Phase III clinical trials (with its quadrivalent VLP influenza vaccine candidate) and pandemic Phase II clinical trials (with its H1N1 pandemic vaccine candidate).
  • As soon as the genetic sequence of a virus is made available, Medicago can develop a clinical-grade vaccine candidate in only a few weeks.

A New Swine Flu Threat Brings 1918 and 2009 Pandemic Deja Vu

Retrieved on: 
Friday, July 3, 2020
Viruses, Health, Contents, Influenza, RTT, Animal virology, Pandemics, Swine influenza, Flu pandemic, Influenza A virus subtype H1N1, Pandemic H1N1/09 virus, Flu pandemic in the United States by state

BALTIMORE, July 3, 2020 /PRNewswire/ --It was just reported that the H1N1 Swine Flu which caused pandemics in 1918 and 2009 may soon return.

Key Points: 
  • BALTIMORE, July 3, 2020 /PRNewswire/ --It was just reported that the H1N1 Swine Flu which caused pandemics in 1918 and 2009 may soon return.
  • Ironically, it is the threat of a new strain of deadly H1N1 Swine Flu that may begin our return-to-normal in just a few months.
  • In 2009, H1N1 Swine Flu influenza researchers strongly recommended that all health-care workers and patients be tested & treated for Vitamin D Deficiency known as VDD [PMID: 20102323].
  • Key to preventing the Swine Flu is to treat the decade-old ignored global pandemic of VDD.

NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

Retrieved on: 
Thursday, July 2, 2020
Viruses, Health, Infectious diseases, Animal virology, RTT, Influenza A virus subtype H1N1, Flu pandemic in the United States, Flu pandemic, Swine influenza, Influenza, Orthomyxoviridae, Influenza pandemic

Prevalent Eurasian Avian-like H1N1 Swine Influenza Virus with 2009 Pandemic Viral Genes Facilitating Human Infection.

Key Points: 
  • Prevalent Eurasian Avian-like H1N1 Swine Influenza Virus with 2009 Pandemic Viral Genes Facilitating Human Infection.
  • (See Link) https://www.pnas.org/content/early/2020/06/23/1921186117?referringSource...
    MIRAMAR, Fla., July 02, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology today announced that the company is launching a vaccine development effort to address the new, emerging pandemic threat from a newly identified swine influenza virus.
  • This emerging virus is similar to the 2009 swine flu virus that is estimated to have killed nearly 500,000 globally.
  • Now, as another pandemic threat is emerging with G4 SA H1N1 swine influenza, we are in position to rapidly respond with our Ii-Key-H1 peptide vaccine for which we have Phase I clinical safety and immunogenicity data.

Last of 12,400 Participants Completes Final Visit in BiondVax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial

Retrieved on: 
Wednesday, July 1, 2020
Health, Vaccination, Medicine, RTT, Influenza vaccines, Vaccines, Influenza vaccine, BiondVax, Influenza pandemic, Flu pandemic, Influenza, Swine influenza

In addition, pandemic influenza, such as the H1N1 Swine Flu pandemic of 2009, is a constant global threat.

Key Points: 
  • In addition, pandemic influenza, such as the H1N1 Swine Flu pandemic of 2009, is a constant global threat.
  • BiondVax (NASDAQ: BVXV) is a Phase 3 clinical stage biopharmaceutical company developing a universal flu vaccine.
  • In a total of seven completed Phase 1/2 and Phase 2 clinical trials enrolling 818 participants, the vaccine has been shown to be safe, well-tolerated, and immunogenic.
  • The ongoing pivotal Phase 3 clinical trial aims to assess safety and effectiveness of M-001 in reducing flu illness and severity.

Pandemic Outbreaks in the Past Decade: Correlation of COVID-19 to Previous Epidemiological Outbreaks in Terms of Policies and Measures of Prevention and Control

Retrieved on: 
Tuesday, June 16, 2020
Articles, Viruses, Health, Global health, Influenza pandemics, RTT, Prevention, Pandemic, Flu pandemic, Influenza, Spanish flu, Influenza A virus subtype H5N1

DUBLIN, June 16, 2020 /PRNewswire/ -- The "Pandemic Outbreaks in the Past Decade: A Research Overview" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 16, 2020 /PRNewswire/ -- The "Pandemic Outbreaks in the Past Decade: A Research Overview" report has been added to ResearchAndMarkets.com's offering.
  • Pandemics are outbreaks of disease that become widespread by the transmission of human-to-human infection.
  • Throughout recent history, disease outbreaks and pandemics include Spanish flu, Hong Kong flu, SARS, H7N9, Ebola, and Zika.
  • Three influenza pandemics occurred in the 20th century: 1918 influenza pandemic (Spanish flu), 1957-1958 pandemic (Asian flu), and the 1968 pandemic (Hong Kong flu).

Pandemic Outbreaks in the Past Decade: A Research Overview - ResearchAndMarkets.com

Retrieved on: 
Friday, June 12, 2020
Infectious diseases, General Health, Health, Articles, Viruses, Health, Influenza pandemics, Global health, Animal virology, Prevention, Flu pandemic, Pandemic, Influenza, Spanish flu, Influenza A virus subtype H5N1

The "Pandemic Outbreaks in the Past Decade: A Research Overview" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pandemic Outbreaks in the Past Decade: A Research Overview" report has been added to ResearchAndMarkets.com's offering.
  • Pandemics are outbreaks of disease that become widespread by the transmission of human-to-human infection.
  • Throughout recent history, disease outbreaks and pandemics include Spanish flu, Hong Kong flu, SARS, H7N9, Ebola, and Zika.
  • Three influenza pandemics occurred in the 20th century: 1918 influenza pandemic (Spanish flu), 1957-1958 pandemic (Asian flu), and the 1968 pandemic (Hong Kong flu).

COVID-19 Patients May Have Lower Stroke Rates Than Previously Suggested

Retrieved on: 
Wednesday, May 20, 2020
RTT, Virus, Influenza A virus subtype H1N1, Flu pandemic, Prevention, Organisms, Stroke, Pandemic H1N1/09 virus, Articles

This contrasts with the rates reported recently in small studies in China and Italy, which ranged from 2 5 percent.

Key Points: 
  • This contrasts with the rates reported recently in small studies in China and Italy, which ranged from 2 5 percent.
  • Then, they compared the characteristics of this group with stroke patients without the virus admitted during the same timeframe, and with patients from the previous year, before the pandemic began.
  • The research team found that stroke patients with COVID-19 disease had more severe symptoms than their counterparts without the virus.
  • This finding may offer a clue to how physicians can better treat stroke occurring in patients who have the virus, the study authors say.

The COVID-19 Fallout: Research Report on the R&D, Economic Impact and Future Implications - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 12, 2020
Health, Infectious diseases, Articles, Viruses, Health, Global health, Influenza pandemics, Zoonoses, Pandemic, Influenza, Flu pandemic, Severe acute respiratory syndrome, Spanish flu

Throughout recent history, disease outbreaks, and pandemics include Spanish flu, Hong Kong flu, SARS, H7N9, Ebola, Zika (WHO, 2011b).

Key Points: 
  • Throughout recent history, disease outbreaks, and pandemics include Spanish flu, Hong Kong flu, SARS, H7N9, Ebola, Zika (WHO, 2011b).
  • The report emphasizes the current pandemic outbreak COVID-19 and its impact on various stakeholders.
  • Reasons for Doing This Study:
    The COVID-19 pandemic outbreak is challenging the global economy and affecting all industries throughout the world.
  • There is a critical need for the development of therapeutics and vaccines to control the transmission and treatment of existing infections.